1. Home
  2. TITN vs ARVN Comparison

TITN vs ARVN Comparison

Compare TITN & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Titan Machinery Inc.

TITN

Titan Machinery Inc.

HOLD

Current Price

$19.98

Market Cap

443.9M

ML Signal

HOLD

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$8.03

Market Cap

516.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TITN
ARVN
Founded
1980
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
443.9M
516.2M
IPO Year
2007
2018

Fundamental Metrics

Financial Performance
Metric
TITN
ARVN
Price
$19.98
$8.03
Analyst Decision
Hold
Buy
Analyst Count
3
19
Target Price
$19.00
$15.05
AVG Volume (30 Days)
147.5K
647.9K
Earning Date
05-21-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
58.84
EPS
N/A
N/A
Revenue
$2,427,107,000.00
$262,600,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.75
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.21
$6.06
52 Week High
$25.00
$14.22

Technical Indicators

Market Signals
Indicator
TITN
ARVN
Relative Strength Index (RSI) 53.06 42.94
Support Level $18.72 $7.90
Resistance Level $20.21 $8.90
Average True Range (ATR) 0.73 0.31
MACD 0.15 -0.01
Stochastic Oscillator 91.68 6.00

Price Performance

Historical Comparison
TITN
ARVN

About TITN Titan Machinery Inc.

Titan Machinery Inc owns and operates a network of full-service agricultural and construction equipment stores. The company sells and repairs agricultural equipment, including machinery and attachments for large-scale farming and home and gardening purposes, as well as construction equipment. It operates through following segments: The Agriculture segment sells, services, and rents machinery and related parts and attachments, for uses ranging from large-scale farming to home and garden use, The construction segment sells, services, and rents machinery, and related parts and attachments, for uses ranging from heavy construction to light industrial machinery use, and the Europe and Australia segments.

About ARVN Arvinas Inc.

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

Share on Social Networks: